These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4158915)

  • 1. The pink spot.
    Lancet; 1965 Dec; 2(7423):1169-70. PubMed ID: 4158915
    [No Abstract]   [Full Text] [Related]  

  • 2. Pink spot in schizophrenia.
    Br Med J; 1966 Jan; 1(5480):119. PubMed ID: 5901567
    [No Abstract]   [Full Text] [Related]  

  • 3. Excretion of 3,4-dimethoxyphenyl-ethylamine in schizophrenia.
    von Studnitz W
    Acta Psychiatr Scand; 1965; 41(1):117-21. PubMed ID: 5861810
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biological schizophrenia research].
    Munkvad I
    Ugeskr Laeger; 1977 Nov; 139(45):2687-8. PubMed ID: 595154
    [No Abstract]   [Full Text] [Related]  

  • 5. The "pink spot", 3,4-dimethoxyphenylethylamine and dopamine. Relationship to Parkinson's disease and to schizophrenia.
    Barbeau A
    Rev Can Biol; 1967 Mar; 26(1):55-79. PubMed ID: 4865100
    [No Abstract]   [Full Text] [Related]  

  • 6. A neurotropic compound identified in urine of schizophrenic patients.
    Friedhoff AJ; Van Winkle E
    Proc Annu Meet Am Psychopathol Assoc; 1966; 54():277-82. PubMed ID: 5951921
    [No Abstract]   [Full Text] [Related]  

  • 7. Schizophrenia and pink spot.
    Stam FC; Heslinga FJ; van Tilburg W
    Psychiatr Neurol Neurochir; 1969; 72(6):513-24. PubMed ID: 5369242
    [No Abstract]   [Full Text] [Related]  

  • 8. "Pink spot" and schizophrenia.
    Ridges AP; Bourdillon RE; Leslie SA; Harper P
    Psychiatr Clin (Basel); 1968; 1(1):44-62. PubMed ID: 4880076
    [No Abstract]   [Full Text] [Related]  

  • 9. Neurochemistry of reward and punishment: some implications for the etiology of schizophrenia.
    Stein L
    J Psychiatr Res; 1971 Aug; 8(3):345-61. PubMed ID: 4939380
    [No Abstract]   [Full Text] [Related]  

  • 10. "Pink spot" and its components in normal and schizophrenic urine.
    Siegel M; Tefft H
    J Nerv Ment Dis; 1971 Jun; 152(6):412-26. PubMed ID: 5562594
    [No Abstract]   [Full Text] [Related]  

  • 11. The "pink spot" and schizophrenia.
    Boulton AA; Felton CA
    Nature; 1966 Sep; 211(5056):1404-5. PubMed ID: 5969835
    [No Abstract]   [Full Text] [Related]  

  • 12. The "pink spot" and schizophrenia.
    Pue AF; Hoare R; Adamson JD
    Can Psychiatr Assoc J; 1969 Aug; 14(4):397-401. PubMed ID: 5811248
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biochemical studies in schizophrenia. On the "pink spot" phenomenon].
    Vogel WH
    Munch Med Wochenschr; 1967 Aug; 109(31):1633-41. PubMed ID: 5631559
    [No Abstract]   [Full Text] [Related]  

  • 14. Abnormal O-methylated dopamine metabolites: the endogenous toxins of schizophrenia or parkinsonism?
    Smith JA; Hartley R
    J Pharm Pharmacol; 1973 May; 25(5):415-6. PubMed ID: 4146400
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemistry and the schizophrenia. Old concepts and new hypothesis.
    Berger PA
    J Nerv Ment Dis; 1981 Feb; 169(2):90-9. PubMed ID: 7009786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced plasma dopamine-beta-hydroxylase activity in familial dysautonomia.
    Weinshilboum RM; Axelrod J
    N Engl J Med; 1971 Oct; 285(17):938-42. PubMed ID: 5096225
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the metabolism of 3,4-dimethoxyphenylethylamine and mescaline in humans.
    Friedhoff AJ; Hollister LE
    Biochem Pharmacol; 1966 Mar; 15(3):269-73. PubMed ID: 5911541
    [No Abstract]   [Full Text] [Related]  

  • 18. Pink spot in childhood schizophrenia.
    Widelitz MM; Feldman W
    Behav Neuropsychiatry; 1969 Apr; 1(1):29-30. PubMed ID: 5398088
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopamine-glutamate interactions: a neural convergence mechanism of common schizophrenia risk variants.
    Tost H; Meyer-Lindenberg A
    Biol Psychiatry; 2011 May; 69(10):912-3. PubMed ID: 21515141
    [No Abstract]   [Full Text] [Related]  

  • 20. beta-Hydroxylation as a possible detoxification mechanism: role in schizophrenia.
    Evans BD; Vogel WH
    Biol Psychiatry; 1977 Aug; 12(4):583-7. PubMed ID: 889987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.